{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:56:11Z","timestamp":1648659371672},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1985,11,1]],"date-time":"1985-11-01T00:00:00Z","timestamp":499651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Res. Exp. Med."],"published-print":{"date-parts":[[1985,11]]},"DOI":"10.1007\/bf01851852","type":"journal-article","created":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T13:17:03Z","timestamp":1120051023000},"page":"457-468","source":"Crossref","is-referenced-by-count":0,"title":["Effects of acipimox on plasma lipids and biliary lipids in healthy subjects"],"prefix":"10.1007","volume":"185","author":[{"given":"W.","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kohlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Nikolaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schlierf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01851852_CR1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1172\/JCI105794","volume":"47","author":"WH Admirand","year":"1968","unstructured":"Admirand WH, Small DM (1968) The physiochemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043\u20131052","journal-title":"J Clin Invest"},{"key":"BF01851852_CR2","first-page":"157","volume":"15","author":"V Ambrogi","year":"1980","unstructured":"Ambrogi V, Cozzi P, Sanjust P, Bertone L, Lovisolo PP, Vangosa GB, Angelucci R (1980) Antilipolytic activity of a series of pyrazine-N-oxides. Eur J Med Chem 15:157\u2013163","journal-title":"Eur J Med Chem"},{"key":"BF01851852_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2362.1979.tb00921.x","volume":"9","author":"B Angelin","year":"1979","unstructured":"Angelin B, Einarsson K, Leijd B (1979) Biliary lipid composition during treatment with different hypolipidemic drugs. Eur J Clin Invest 9:185\u2013190","journal-title":"Eur J Clin Invest"},{"key":"BF01851852_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2362.1984.tb00707.x","volume":"14","author":"B Angelin","year":"1984","unstructured":"Angelin B, Einarsson K, Leijd B (1984) Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemia. Eur J Clin Invest 14:73\u201378","journal-title":"Eur J Clin Invest"},{"key":"BF01851852_CR5","first-page":"28","volume-title":"Nutrition and health. A survey of young men and women in Heidelberg. Annals of Nutrition and Metabolism","author":"L Arab","year":"1982","unstructured":"Arab L, Schellenberg B, Schlierf G (1982) Nutrition and health. A survey of young men and women in Heidelberg. Annals of Nutrition and Metabolism. Karger, Basel, pp 28\u201332"},{"key":"BF01851852_CR6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01072597","volume":"23","author":"MC Bateson","year":"1978","unstructured":"Bateson MC, McLean D, Ross PE, Bouchier IAD (1978) Clofibrate therapy and gallstone induction. Dig Dis 23:623\u2013628","journal-title":"Dig Dis"},{"key":"BF01851852_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0021-9150(77)90127-7","volume":"26","author":"LA Carlson","year":"1977","unstructured":"Carlson LA, Olsson AG, Ballantyne D (1977) On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridemia in type IV and type V hyperlipoproteinemias. Atherosclerosis 26:603\u2013609","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0021-9150(80)90121-5","volume":"35","author":"MC Cheung","year":"1980","unstructured":"Cheung MC, Albers JA, Wahl PW, Hazzard WR (1980) High density lipoproteins during hypolipidemic therapy. Atherosclerosis 35:215\u2013228","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR9","unstructured":"Crepaldi G, Avogaro P, Di Perri T, Mancini M, Paoletti R, Sirtori CR, Strano A, Ventura S (1981) Acipimox versus placebo. A double-blind controlled trial in primary hyperlipidemia. Symposium on Lipoproteins and Coronary Atherosclerosis, Lugano, p 109 [Abstract]"},{"key":"BF01851852_CR10","first-page":"28","volume":"4","author":"SC Enger","year":"1978","unstructured":"Enger SC, Erikssen J, Johnsen V, Samuelsen A, Herbjornsen K, Laws EA (1978) The effect of clofibrate on high density lipoprotein and total cholesterol in patients with coronary heart disease. Artery 4:28\u201335","journal-title":"Artery"},{"key":"BF01851852_CR11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/clpt.1980.236","volume":"28","author":"LM Fucella","year":"1980","unstructured":"Fucella LM, Goldaniga G, Lovisolo PP, Maggi E, Musatti L, Mandelli V, Sirtori CR (1980) Inhibition of lipolysis by nicotinic acid and by Acipimox. Clin Pharmacol Ther 28:790\u2013795","journal-title":"Clin Pharmacol Ther"},{"key":"BF01851852_CR12","first-page":"354","volume":"89","author":"SM Grundy","year":"1977","unstructured":"Grundy SM, Mok HYI (1977) Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. J Lab Clin Med 89:354\u2013366","journal-title":"J Lab Clin Med"},{"key":"BF01851852_CR13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-2275(20)39388-3","volume":"13","author":"SM Grundy","year":"1972","unstructured":"Grundy SM, Ahrens EH Jr, Salen G, Schreibman PH, Nestel PJ (1972) Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res 13:531\u2013551","journal-title":"J Lipid Res"},{"key":"BF01851852_CR14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-2275(20)34737-4","volume":"22","author":"SM Grundy","year":"1981","unstructured":"Grundy SM, Mok HYI, Zech L, Bermann M (1981) Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 22:24\u201336","journal-title":"J Lipid Res"},{"key":"BF01851852_CR15","first-page":"4390","volume":"33","author":"W Haberbosch","year":"1983","unstructured":"Haberbosch W, Gnasso A, Ziegler WJ, Augustin J (1983) Einflu\u00df von Etofyllinclofibrat auf den Lipoproteinstoffwechsel bei Patienten mit heterozygoter Typ-IIa-Hyperlipoprotein\u00e4mie. Therapiewoche 33:4390\u20134398","journal-title":"Therapiewoche"},{"key":"BF01851852_CR16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02020933","volume":"10","author":"FG Hegard","year":"1970","unstructured":"Hegard FG, Dam H (1970) The solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ern\u00e4hrungswiss 10:223\u2013233","journal-title":"Z Ern\u00e4hrungswiss"},{"key":"BF01851852_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9343(79)90489-3","volume":"66","author":"I Hjermann","year":"1979","unstructured":"Hjermann I, Enger SC, Helgeland A, Holme I, Leren P, Trygg K (1979) The effect of dietary changes on high density lipoprotein cholesterol. The Oslo study. Am J Med 66:105\u2013109","journal-title":"Am J Med"},{"key":"BF01851852_CR18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1172\/JCI107321","volume":"52","author":"RT Holzbach","year":"1973","unstructured":"Holzbach RT, Marshi M, Olszewski M, Holan K (1973) Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 52:1467\u20131479","journal-title":"J Clin Invest"},{"key":"BF01851852_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02533580","volume":"14","author":"S Hulley","year":"1979","unstructured":"Hulley S, Ashman P, Kuller L, Lasser N, Sherwin R (1979) HDL-Cholesterol levels in the multiple risk factor intervention trial (MRFIT) by the MRFIT group. Lipids 14:119\u2013125","journal-title":"Lipids"},{"key":"BF01851852_CR20","unstructured":"Irsigler K, Broell H, Brusco O, Cardonett L, Noseda G, Fragiocomo C, Penalva J, Prokesch H, Najemnik C, Smud R, Werner I, Croppi W, Musatti L (1981) Multicenter double-blind controlled trial with Acipimox in Type IV hyperlipoproteinemia. Symposium on Lipoproteins and Coronary Atherosclerosis, Lugano, p 111 [Abstr]"},{"key":"BF01851852_CR21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/clinchem\/28.2.396a","volume":"28","author":"M Kohlmeier","year":"1982","unstructured":"Kohlmeier M, Schlierf G (1982) Effect of storage on HDL-cholesterol measurements. Clin Chem 28:396\u2013397","journal-title":"Clin Chem"},{"key":"BF01851852_CR22","unstructured":"Kohlmeier M, Hill T, Remer P, Schlierf G (1985) Influence of bezafibrate on lipid metabolism in healthy men. Atherosclerosis (in press)"},{"key":"BF01851852_CR23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cpt1977222154","volume":"22","author":"BJ Kudchodkar","year":"1977","unstructured":"Kudchodkar BJ, Sodhi HS, Horlick L, Mason DT (1977) Effects of clofibrate on cholesterol metabolism. Clin Pharmacol Ther 22:154\u2013163","journal-title":"Clin Pharmacol Ther"},{"key":"BF01851852_CR24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cpt1978243354","volume":"24","author":"BJ Kudchodkar","year":"1978","unstructured":"Kudchodkar BJ, Sodhi HS, Horlick L, Mason DT (1978) Mechanisms of hypolipidemic action of nicotinic acid. Clin Pharmacol Ther 24:354\u2013373","journal-title":"Clin Pharmacol Ther"},{"key":"BF01851852_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6989(81)80016-1","volume":"13","author":"PP Lovisolo","year":"1981","unstructured":"Lovisolo PP, Vangosa GB, Orsini G, Ronchi R, Angelucci R, Valzelli G (1981) Pharmacological profile of a new antilipolytic agent: 5-methylpyrazine-2-carboxylic acid-4-oxide (Acipimox). I. Mechanism of action. Pharmacol Res Commun 13:151\u2013161","journal-title":"Pharmacol Res Commun"},{"key":"BF01851852_CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0031-6989(81)80017-3","volume":"13","author":"PP Lovisolo","year":"1981","unstructured":"Lovisolo PP, Vangosa GB, Orsini G, Ronchi R, Angelucci R (1981) Pharmacological profile of a new antilipolytic agent: 5-methylpyrazine-2-carboxylic acid-4-oxide (Acipimox). II. Antilipolytic and blood lipid lowering activity. Pharmacol Res Commun 13:163\u2013174","journal-title":"Pharmacol Res Commun"},{"key":"BF01851852_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0009-8981(68)90383-5","volume":"20","author":"TA Miettinen","year":"1968","unstructured":"Miettinen TA (1968) Effect of nicotinic acid on catabolism and synthesis of cholesterol in man. Clin Chim Acta 20:43\u201351","journal-title":"Clin Chim Acta"},{"key":"BF01851852_CR28","first-page":"111","volume":"8","author":"M Miettinen","year":"1976","unstructured":"Miettinen M, Turpeinen O, Karvonen MJ, Paavilainen E, Elosuo R (1976) Prevalence of cholelithiasis in men and women ingesting a serum-cholesterol-lowering diet. Ann Clin Res 8:111\u2013116","journal-title":"Ann Clin Res"},{"key":"BF01851852_CR29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/BF01489714","volume":"56","author":"R Mordasini","year":"1978","unstructured":"Mordasini R, Twelsiek F, Oster P, Schellenberg B, Raetzer H, Heuck CC, Schlierf G (1978) Abnormal low density lipoprotein in children with familial hypercholesterolemia\u2014effect of polyanion exchange resins. Klin Wochenschr 56:805\u2013808","journal-title":"Klin Wochenschr"},{"key":"BF01851852_CR30","first-page":"95","volume":"112","author":"R Mordasini","year":"1982","unstructured":"Mordasini R, Riesen W, Oster P, Riva G (1982) Verhalten der High-Density-Lipoproteine (HDL) unter medikament\u00f6ser lipidsenkender Behandlung. Schweiz Med Wochenschr 112:95\u201398","journal-title":"Schweiz Med Wochenschr"},{"key":"BF01851852_CR31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/030006058100900515","volume":"9","author":"L Musatti","year":"1981","unstructured":"Musatti L, Maggi E, Moro E, Valzelle G, Tamassia V (1981) Bioavailability and pharmacokinetics in man of Acipimox, a new antilipolytic and hypolipemic agent. J Int Med Res 9:381\u2013386","journal-title":"J Int Med Res"},{"key":"BF01851852_CR32","first-page":"1790","volume":"112","author":"G Noseda","year":"1982","unstructured":"Noseda G, Fragiacomo C, Cairoli R (1982) Behandlung der Hyperlipid\u00e4mie Typ II mit Acipimox. Schweiz Med Wochenschr 112:1790\u20131791","journal-title":"Schweiz Med Wochenschr"},{"key":"BF01851852_CR33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/hrt.40.10.1069","volume":"40","author":"MF Oliver","year":"1978","unstructured":"Oliver MF, Heady JA, Morris JN, Cooper J (1978) A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 40:1069\u20131118","journal-title":"Br Heart J"},{"key":"BF01851852_CR34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02535680","volume":"16","author":"P Oster","year":"1981","unstructured":"Oster P, Schlierf G, Heuck CC, Hahn S, Szymanski H, Schellenberg B (1981) Diet and high density lipoproteins. Lipids 16:93\u201397","journal-title":"Lipids"},{"key":"BF01851852_CR35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0002-9343(77)90555-1","volume":"63","author":"JR Patsch","year":"1977","unstructured":"Patsch JR, Yeshurun D, Jackson RL, Gotto AM Jr (1977) Effects of clofibrate, nicotinic acid and diet on the properties of plasma lipoproteins in a subject with type III hyperlipoproteinemia. Am J Med 63:1001\u20131009","journal-title":"Am J Med"},{"key":"BF01851852_CR36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0016-5085(74)80045-4","volume":"66","author":"D Pertsemlidis","year":"1974","unstructured":"Pertsemlidis D, Panveliwalla D, Ahrens EH Jr (1974) Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetic in man. Gastroenterology 66:565\u2013573","journal-title":"Gastroenterology"},{"key":"BF01851852_CR37","first-page":"770","volume":"125","author":"G Schlierf","year":"1977","unstructured":"Schlierf G, Vogel G, Heuck CC, Oster P, Raetzer H, Schellenberg B (1977) Zur Di\u00e4ttherapie der famili\u00e4ren Hypercholesterin\u00e4mie bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 125:770\u2013773","journal-title":"Monatsschr Kinderheilkd"},{"key":"BF01851852_CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9150(78)90116-8","volume":"30","author":"G Schlierf","year":"1978","unstructured":"Schlierf G, Oster P, Heuck CC, Raetzer H, Schellenberg B (1978) Sitosterol in juvenile type II hyperlipoproteincmia. Atherosclerosis 30:245\u2013248","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4684-0967-3_2","volume-title":"Drugs, lipid metabolism, and atherosclerosis","author":"G Schlierf","year":"1978","unstructured":"Schlierf G, Oster P, Lang PD, Raetzer H, Schellenberg B, Heuck CC (1978) Lipoprotein metabolism in man. In: Kritchevsky D, Paoletti R, Holmes WL (eds) Drugs, lipid metabolism, and atherosclerosis. Plenum Press, New York, pp 29\u201343"},{"key":"BF01851852_CR40","first-page":"1743","volume":"109","author":"G Schlierf","year":"1979","unstructured":"Schlierf G, Nikolaus T, Stiehl A, Heuck CC, Middelhoff G, Riesen W, Oster P (1979) Zur Wirkung lipidspiegelsenkender Kostformen auf Gallenlipide und Plasmalipoproteine bei Normalpersonen. Schweiz Med Wochenschr 109:1743\u20131747","journal-title":"Schweiz Med Wochenschr"},{"key":"BF01851852_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0021-9150(80)90213-0","volume":"36","author":"G Schlierf","year":"1980","unstructured":"Schlierf G, Chwat M, Feuerborn E, W\u00fclfinghof E, Heuck CC, Kohlmeier M, Oster P, Stiehl A (1980) Biliary and plasma lipids and lipid-lowering chemotherapy. Atherosclerosis 36:323\u2013329","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR42","first-page":"165","volume":"122","author":"G Schlierf","year":"1980","unstructured":"Schlierf G, Fischer H, Roche A, Stiehl A, Oster P, Schellenberg B, Vollmar J (1980) Gallenlipide unter Bezafibrat. MMW 122:165\u2013168","journal-title":"MMW"},{"key":"BF01851852_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0021-9150(82)90077-6","volume":"41","author":"G Schlierf","year":"1982","unstructured":"Schlierf G, Mrozik K, Heuck CC, Middelhoff G, Oster P, Riesen W, Schellenberg B (1982) \u201cLow dose\u201d colestipol in children, adolescents and young adults with familial hypercholesterolemia. Atherosclerosis 41:133\u2013138","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR44","first-page":"247","volume-title":"Different doses of Acipimox in the treatment of hyperlipoproteinemia","author":"W Schwartzkopff","year":"1982","unstructured":"Schwartzkopff W, Luley C, Lehman-Leo W (1982) Different doses of Acipimox in the treatment of hyperlipoproteinemia. Sixth International Symposium on Atherosclerosis, Berlin, p 247 [Abstr]"},{"key":"BF01851852_CR45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0021-9150(81)90042-3","volume":"38","author":"CR Sirtori","year":"1981","unstructured":"Sirtori CR, Gianfranceschi G, Sirtori M, Bernini FF, Descovich G, Montaguti U, Fucella LM, Musatti L (1981) Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with Acipimox, a new inhibitor of lipolysis. Atherosclerosis 38:267\u2013271","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR46","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI109078","volume":"61","author":"J Shepherd","year":"1978","unstructured":"Shepherd J, Packard J, Patsch JR (1978) Effects of polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A\u2013I. J Clin Invest 61:1582\u20131592","journal-title":"J Clin Invest"},{"key":"BF01851852_CR47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0021-9150(79)90036-4","volume":"33","author":"J Shepherd","year":"1979","unstructured":"Shepherd J, Packard CJ, Morgan HG, Third JLHC, Stewart JM, Lawrie TDV (1979) The effects of cholestyramine on high density lipoprotein metabolism. Atherosclerosis 33:433\u2013444","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM197301042880106","volume":"288","author":"RAL Sturdevant","year":"1973","unstructured":"Sturdevant RAL, Pearce ML, Dayton S (1973) Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. N Engl J Med 288:24\u201327","journal-title":"N Engl J Med"},{"key":"BF01851852_CR49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(85)90165-0","volume":"55","author":"PMJ Stuyt","year":"1985","unstructured":"Stuyt PMJ, Stalenhoef AFH, Demacker PNM, Laar A van't (1985) A comparative study of the effects of Acipimox and clofibrate in type III and type IV hyperlipoproteinemia. Atherosclerosis 55:51\u201362","journal-title":"Atherosclerosis"},{"key":"BF01851852_CR50","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM197705262962101","volume":"296","author":"The Coronary Drug Project Research Group","year":"1977","unstructured":"The Coronary Drug Project Research Group (1977) Gallbladder disease as a side effect of drugs influencing lipid metabolism. N Engl J Med 296:1185\u20131190","journal-title":"N Engl J Med"},{"key":"BF01851852_CR51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0016-5085(19)33056-2","volume":"65","author":"PJ Thomas","year":"1973","unstructured":"Thomas PJ, Hofmann AF (1973) A simple calculation of the lithogenic index of bile expressing biliary lipid composition on rectangular coordinates. Gastroenterology 65:698\u2013700","journal-title":"Gastroenterology"},{"key":"BF01851852_CR52","first-page":"123","volume-title":"Lipoproteine und Herzinfarkt","author":"IG Wechsler","year":"1979","unstructured":"Wechsler IG, Hutt V, Kl\u00f6r HU, Bode G, Ditschuneit H (1979) Einflu\u00df von Bezafibrat in den Dosierungen von 450 und 600 mg\/Tag auf die Lipide und Lipoproteine von Patienten mit verschiedenen Hyperlipoprotein\u00e4mie-Typen. In: Greten H, Lang PD, Schettler G (Hrsg) Lipoproteine und Herzinfarkt. Witzstrock, Baden-Baden, S 123\u2013128"},{"key":"BF01851852_CR53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0026-0495(79)90067-2","volume":"28","author":"JL Witztum","year":"1979","unstructured":"Witztum JL, Schonfeld G, Weidman SW, Giese WE, Dillingham MA (1979) Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins. Metabolism 28:221\u2013229","journal-title":"Metabolism"}],"container-title":["Research in Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01851852.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01851852\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01851852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T17:45:59Z","timestamp":1626111959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01851852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["BF01851852"],"URL":"https:\/\/doi.org\/10.1007\/bf01851852","relation":{},"ISSN":["0300-9130","1433-8580"],"issn-type":[{"value":"0300-9130","type":"print"},{"value":"1433-8580","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}